Stephen Smith, M.D.
Stephen Smith, M.D.
Associate Professor
Clinical Research Division, Fred Hutch
Dr. Stephen Smith is a medical oncologist who cares for patients with lymphoma and other blood disorders. His research focuses on developing new, targeted therapies to treat these diseases.
Other Appointments & Affiliations
Medical Oncologist
Seattle Cancer Care Alliance
Associate Professor
University of Washington
Education
M.D., Keck School of Medicine, University of Southern California, 2002
B.S., Biological Sciences, Stanford University, 1997
Current Projects
NCCN grant, 2014 - 2016 "Oprozomib +/- Rituximab: Response-Adapted Therapy in Untreated Waldenström’s Macroglobulinemia". Collaborative clinical trial with correlative studies in conjunction with the University of Utah Huntsman Cancer Institute
Active Clinical Trials
Doxorubicin Hydrochloride, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma
Study Number: 9844
Phase: II
Rituximab and Pembrolizumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma
Study Number: 9469
Phase: II
A Study of Bendamustine and Rituximab Alone Versus in Combination With Acalabrutinib in Subjects With Previously Untreated Mantle Cell Lymphoma
Study Number: 20170154
Phase: III
Phase 1/2A Dose Escalation Study in CLL, SLL or NHL
Study Number: 20170188
Phase: I/II
Dr. Smith in the News
For the Media
The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.
Email media@fredhutch.org or call 206.667.2210